We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -15.00 | -0.91% | 1,636.00 | 1,638.00 | 1,639.00 | 1,661.50 | 1,635.50 | 1,656.50 | 4,329,161 | 16:35:12 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.69 | 67.46B |
From Apr 2021 to Apr 2024
TIDMGSK
RNS Number : 5022T
GlaxoSmithKline PLC
24 November 2021
GlaxoSmithKline plc
GSK publishes provisional dividend dates
GSK announces the following dividend dates for 2022:
Hot Features
Premium
Results Announcement Ex-dividend Record date Last date for Payable
date date DRIP elections
Q1 2022 Wednesday 27 Thursday 19 Friday 20 Thursday 16 Thursday 7
April 2022 May 2022 May 2022 June 2022 July 2022
--------------- --------------- --------------- ------------------- --------------
Q2 2022 Wednesday 27 Thursday 18 Friday 19 Thursday 15 Thursday 6
July 2022 August 2022 August 2022 September 2022 October 2022
--------------- --------------- --------------- ------------------- --------------
Q3 2022 Wednesday 2 Thursday 17 Friday 18 Monday 19 December Thursday 12
November 2022 November 2022 November 2022 2022 January 2023
--------------- --------------- --------------- ------------------- --------------
Q4 2022 Wednesday 1 Thursday 23 Friday 24 Tuesday 21 Thursday 13
February 2023 February 2023 February 2023 March 2023 April 2023
(Final)
--------------- --------------- --------------- ------------------- --------------
These dates are indicative and may be subject to change.
V A Whyte
Company Secretary
24 November 2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCEZLFLFFLEFBV
(END) Dow Jones Newswires
November 24, 2021 10:59 ET (15:59 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
